128 related articles for article (PubMed ID: 10681646)
21. Proximal tubular cells promote fibrogenesis by TGF-beta1-mediated induction of peritubular myofibroblasts.
Abbate M; Zoja C; Rottoli D; Corna D; Tomasoni S; Remuzzi G
Kidney Int; 2002 Jun; 61(6):2066-77. PubMed ID: 12028447
[TBL] [Abstract][Full Text] [Related]
22. Glomerular and tubular induction of the transcription factor c-Jun in human renal disease.
De Borst MH; Prakash J; Melenhorst WB; van den Heuvel MC; Kok RJ; Navis G; van Goor H
J Pathol; 2007 Oct; 213(2):219-28. PubMed ID: 17891746
[TBL] [Abstract][Full Text] [Related]
23. Constitutive expression of HGF modulates renal epithelial cell phenotype and induces c-met and fibronectin expression.
Liu Y; Centracchio JN; Lin L; Sun AM; Dworkin LD
Exp Cell Res; 1998 Jul; 242(1):174-85. PubMed ID: 9665815
[TBL] [Abstract][Full Text] [Related]
24. A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition.
Yang J; Dai C; Liu Y
J Am Soc Nephrol; 2005 Jan; 16(1):68-78. PubMed ID: 15537870
[TBL] [Abstract][Full Text] [Related]
25. Expression of insulin-like growth factor-I and transforming growth factor-beta in hypokalemic nephropathy in the rat.
Tsao T; Fawcett J; Fervenza FC; Hsu FW; Huie P; Sibley RK; Rabkin R
Kidney Int; 2001 Jan; 59(1):96-105. PubMed ID: 11135062
[TBL] [Abstract][Full Text] [Related]
26. Renal functional decline and glomerulotubular injury are arrested but not restored by release of unilateral ureteral obstruction (UUO).
Chaabane W; Praddaude F; Buleon M; Jaafar A; Vallet M; Rischmann P; Galarreta CI; Chevalier RL; Tack I
Am J Physiol Renal Physiol; 2013 Feb; 304(4):F432-9. PubMed ID: 23220725
[TBL] [Abstract][Full Text] [Related]
27. Bone morphogenic protein-7 (BMP-7), a novel therapy for diabetic nephropathy.
Wang S; Chen Q; Simon TC; Strebeck F; Chaudhary L; Morrissey J; Liapis H; Klahr S; Hruska KA
Kidney Int; 2003 Jun; 63(6):2037-49. PubMed ID: 12753291
[TBL] [Abstract][Full Text] [Related]
28. Osmotic polyuria: an overlooked mechanism in diabetic nephropathy.
Wang S; Mitu GM; Hirschberg R
Nephrol Dial Transplant; 2008 Jul; 23(7):2167-72. PubMed ID: 18456680
[TBL] [Abstract][Full Text] [Related]
29. Hepatocyte growth factor suppresses transforming growth factor-beta-1 and type III collagen in human primary renal fibroblasts.
Mou S; Wang Q; Shi B; Gu L; Ni Z
Kaohsiung J Med Sci; 2009 Nov; 25(11):577-87. PubMed ID: 19858036
[TBL] [Abstract][Full Text] [Related]
30. Renal function in diabetic disease models: the tubular system in the pathophysiology of the diabetic kidney.
Vallon V; Thomson SC
Annu Rev Physiol; 2012; 74():351-75. PubMed ID: 22335797
[TBL] [Abstract][Full Text] [Related]
31. Proteinuria and growth factors in the development of tubulointerstitial injury and scarring in kidney disease.
Hirschberg R; Wang S
Curr Opin Nephrol Hypertens; 2005 Jan; 14(1):43-52. PubMed ID: 15586015
[TBL] [Abstract][Full Text] [Related]
32. Transforming growth factor-beta in glomerular injury.
Border WA; Noble NA
Exp Nephrol; 1994; 2(1):13-7. PubMed ID: 8081992
[No Abstract] [Full Text] [Related]
33. Endogenous hepatocyte growth factor ameliorates chronic renal injury by activating matrix degradation pathways.
Liu Y; Rajur K; Tolbert E; Dworkin LD
Kidney Int; 2000 Nov; 58(5):2028-43. PubMed ID: 11044223
[TBL] [Abstract][Full Text] [Related]
34. The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury?
Gilbert RE; Cooper ME
Kidney Int; 1999 Nov; 56(5):1627-37. PubMed ID: 10571771
[TBL] [Abstract][Full Text] [Related]
35. Tubular atrophy, interstitial fibrosis, and inflammation in type 2 diabetic db/db mice. An accelerated model of advanced diabetic nephropathy.
Ninichuk V; Kulkarni O; Clauss S; Anders H-
Eur J Med Res; 2007 Aug; 12(8):351-5. PubMed ID: 17933712
[TBL] [Abstract][Full Text] [Related]
36. Expression of TGF-beta-induced matrix protein betaig-h3 is up-regulated in the diabetic rat kidney and human proximal tubular epithelial cells treated with high glucose.
Lee SH; Bae JS; Park SH; Lee BH; Park RW; Choi JY; Park JY; Ha SW; Kim YL; Kwon TH; Kim IS
Kidney Int; 2003 Sep; 64(3):1012-21. PubMed ID: 12911551
[TBL] [Abstract][Full Text] [Related]
37. Proteinuria as a mediator of tubulointerstitial injury.
Abbate M; Remuzzi G
Kidney Blood Press Res; 1999; 22(1-2):37-46. PubMed ID: 10352406
[TBL] [Abstract][Full Text] [Related]
38. Mechanisms of disease: the hypoxic tubular hypothesis of diabetic nephropathy.
Singh DK; Winocour P; Farrington K
Nat Clin Pract Nephrol; 2008 Apr; 4(4):216-26. PubMed ID: 18268525
[TBL] [Abstract][Full Text] [Related]
39. The growth hormone-insulin-like growth factor axis in kidney.
Hammerman MR
Am J Physiol; 1989 Oct; 257(4 Pt 2):F503-14. PubMed ID: 2679142
[TBL] [Abstract][Full Text] [Related]
40. Cyclosporin exerts a direct fibrogenic effect on human tubulointerstitial cells: roles of insulin-like growth factor I, transforming growth factor beta1, and platelet-derived growth factor.
Johnson DW; Saunders HJ; Johnson FJ; Huq SO; Field MJ; Pollock CA
J Pharmacol Exp Ther; 1999 Apr; 289(1):535-42. PubMed ID: 10087047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
